Varda Space Industries, a company that operates reentry spacecraft for pharmaceutical and hypersonics research applications, has raised $251 million as it prepares to launch three missions in the next month.
The company said W-8 will carry an interior payload from Canopy Aerospace & Defense to monitor the performance of the spacecraft’s heat shield during reentry, while the heat shield itself will test new thermal protection materials from the Air Force Research Laboratory’s Prometheus program and another undisclosed Defense Department partner.
W-9 will carry a navigation system inside the spacecraft provided by the Defense Department that will collect data during hypersonic flight. The heat shield will test next-generation composite materials from Syensqo.
Varda is also preparing to launch W-7 on a separate mission later in October. That mission will focus on pharmaceutical research, testing a new cancer medicine called PROTAC that shows promise but is difficult to formulate in ways the body can absorb effectively. Varda, which developed the pharmaceutical payload internally, will test whether the microgravity environment can help produce alternative crystal structures that are more effective.
